Redx Pharma PLC (LON:REDX) has appointed a new chief financial officer with both industry and banking experience.
Peter Collum, who joins immediately and will be based in the New York area, was CFO and chief business officer of late-stage biopharma company Pharmnext, which he joined in 2019 after 17 years with the boutique investment bank, MTS Health Partners.
“This is an exciting stage of Redx’s development and growth as we continue to progress on lead assets in oncology and fibrosis,” said Redx chief executive, Lisa Anson.
“Peter’s extensive experience in the US and with US investors will be invaluable as we continue to deliver on our ambition towards becoming a leading biotech company with a robust pipeline of valuable, differentiated targeted medicines in areas of high unmet medical need.”
Collum succeeds James Mead, who has taken on the role of chief operating officer.